---
document_datetime: 2023-09-21 21:11:10
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/aripiprazole-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: aripiprazole-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.6908776
conversion_datetime: 2025-12-29 22:48:05.010383
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Aripiprazole Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                            |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0026              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 11/07/2022                          |                                             | SmPC and PL                      | Section 4.8 of the SmPC has been updated to add ' blood prolactine decreased ' in the tabulated list of all adverse reactions.The PL has been updated accordingly. |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0025   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                    | 13/06/2022   |            | SmPC                             |                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0024   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 02/12/2021   |            | Annex II and PL                  |                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0023/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 15/11/2021   |            | SmPC and PL                      |                                                                                                                                                                                                                                                                                                                                                                                                                       |
| R/0019    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 23/07/2020   | 30/09/2020 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-riskbalance of Aripiprazole Accord in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. Changes were made to the PI to bring it in line with the current Agency/QRD template,SmPC guideline and other relevant guideline(s). |

<div style=\"page-break-after: always\"></div>

| IB/0022/G   | a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                               | 29/06/2020   | 30/09/2020   | SmPC, Annex II and PL   | This was an application for the MAH   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------------|---------------------------------------|
| IA/0021     | B.II.b.2.a - Change to importer,batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                | 04/06/2020   | n/a          |                         |                                       |
|             | application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an alreadyapproved manufacturer | 25/02/2020   | 13/07/2020   | Annex II and PL         | IAIN/0018/G This was an               |
| IB/0017     | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                            | 08/08/2019   | n/a          |                         |                                       |

<div style=\"page-break-after: always\"></div>

| IB/0016   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                          | 14/06/2019   | 13/07/2020   | SmPC and PL            |                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|-----------------|
| IAIN/0015 | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a manufacturer (replacement or addition)                                                                                                                                                                                                                                                                                                                                                       | 17/05/2019   | n/a          |                        | new             |
| IA/0014/G | This was an application for a group of variations. B.II.b.2.a - Change to importer,batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer,batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch | 08/03/2019   | n/a          |                        | control/testing |
| T/0013    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 18/01/2019   | 05/03/2019   | SmPC, Labelling and PL |                 |

<div style=\"page-break-after: always\"></div>

| IAIN/0012   | - Change to importer, batch release and quality control testing of the FP - batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 12/10/2018   | 31/01/2019   | Annex II and PL   | B.II.b.2.c.2 arrangements Including   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------|---------------------------------------|
| IAIN/0011/G | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a - Change to importer,batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - control/testing | 12/10/2018   | 31/01/2019   | Annex II and PL   | Not including batch                   |
| IA/0010     | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originallyapproved batch size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 04/09/2018   | n/a          |                   |                                       |
| IAIN/0009/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 17/08/2018   | n/a          |                   |                                       |

<div style=\"page-break-after: always\"></div>

|         | Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an alreadyapproved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an alreadyapproved manufacturer   |            |            |             | B.III.1.a.1 -   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------|
| IA/0008 | B.II.e.3.a - Change in test procedure for the immediate packaging of the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                               | 06/07/2018 | n/a        |             |                 |
| IB/0007 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                          | 15/02/2018 | 31/01/2019 | SmPC and PL |                 |
| IA/0006 | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                      | 29/11/2017 | n/a        |             |                 |
| IA/0005 | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originallyapproved batch size                                                                                                                                                                                                             | 20/04/2017 | n/a        |             |                 |
| IB/0004 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following                                                                                                                                                                                                                                                                        | 22/03/2017 | 15/11/2017 | Annex II    |                 |

<div style=\"page-break-after: always\"></div>

|             | of the same change for the reference - Implementation of change(s) for which NO additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                                                                                                    |            |            |                        | assessment product new the   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------|
| IB/0003     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                          | 05/12/2016 | 15/11/2017 | SmPC and Labelling     |                              |
| IB/0002     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                          | 07/07/2016 | 12/12/2016 | SmPC and PL            |                              |
| IAIN/0001/G | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets,ampoules,etc.) in a pack - Change within the range of the currentlyapproved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets,ampoules,etc.) in a pack - Change within the range of the currentlyapproved pack sizes B.II.e.5.a.1 - Change in pack size of the finished | 17/12/2015 | 12/12/2016 | SmPC, Labelling and PL |                              |

<div style=\"page-break-after: always\"></div>

| tablets,ampoules,etc.) in a pack - Change within the range of the currentlyapproved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets,ampoules,etc.) in a pack - Change within the range of the currentlyapproved pack sizes   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|